80 related articles for article (PubMed ID: 2172799)
1. Interactions of cathepsin-D and insulin-like growth factor-II (IGF-II) on the IGF-II/mannose-6-phosphate receptor in human breast cancer cells and possible consequences on mitogenic activity of IGF-II.
Mathieu M; Rochefort H; Barenton B; Prebois C; Vignon F
Mol Endocrinol; 1990 Sep; 4(9):1327-35. PubMed ID: 2172799
[TBL] [Abstract][Full Text] [Related]
2. Mannose-6-phosphate/insulin-like growth factor-II receptor is a receptor for retinoic acid.
Kang JX; Li Y; Leaf A
Proc Natl Acad Sci U S A; 1997 Dec; 94(25):13671-6. PubMed ID: 9391084
[TBL] [Abstract][Full Text] [Related]
3. Insulin-Like Growth Factor-II/Cation-Independent Mannose 6-Phosphate Receptor in Neurodegenerative Diseases.
Wang Y; MacDonald RG; Thinakaran G; Kar S
Mol Neurobiol; 2017 May; 54(4):2636-2658. PubMed ID: 26993302
[TBL] [Abstract][Full Text] [Related]
4. Structure and function of the human Gly1619Arg polymorphism of M6P/IGF2R domain 11 implicated in IGF2 dependent growth.
Rezgui D; Williams C; Savage SA; Prince SN; Zaccheo OJ; Jones EY; Crump MP; Hassan AB
J Mol Endocrinol; 2009 Apr; 42(4):341-56. PubMed ID: 19208780
[TBL] [Abstract][Full Text] [Related]
5. CIM6P/IGF-2 Receptor Ligands Reverse Deficits in Angelman Syndrome Model Mice.
Cruz E; Descalzi G; Steinmetz A; Scharfman HE; Katzman A; Alberini CM
Autism Res; 2021 Jan; 14(1):29-45. PubMed ID: 33108069
[TBL] [Abstract][Full Text] [Related]
6. Two Faces of Cathepsin D: Physiological Guardian Angel and Pathological Demon.
Khalkhali-Ellis Z; Hendrix MJ
Biol Med (Aligarh); 2014 Jul; 6(2):. PubMed ID: 25663755
[TBL] [Abstract][Full Text] [Related]
7. A novel Fc-engineered cathepsin D-targeting antibody enhances ADCC, triggers tumor-infiltrating NK cell recruitment, and improves treatment with paclitaxel and enzalutamide in triple-negative breast cancer.
Desroys du Roure P; Lajoie L; Mallavialle A; Alcaraz LB; Mansouri H; Fenou L; Garambois V; Rubio L; David T; Coenon L; Boissière-Michot F; Chateau MC; Ngo G; Jarlier M; Villalba M; Martineau P; Laurent-Matha V; Roger P; Guiu S; Chardès T; Gros L; Liaudet-Coopman E
J Immunother Cancer; 2024 Jan; 12(1):. PubMed ID: 38290768
[TBL] [Abstract][Full Text] [Related]
8. Crystal structure of human PLD1 provides insight into activation by PI(4,5)P
Bowling FZ; Salazar CM; Bell JA; Huq TS; Frohman MA; Airola MV
Nat Chem Biol; 2020 Apr; 16(4):400-407. PubMed ID: 32198492
[TBL] [Abstract][Full Text] [Related]
9. Estrogen receptor-beta is a potential target for triple negative breast cancer treatment.
Austin D; Hamilton N; Elshimali Y; Pietras R; Wu Y; Vadgama J
Oncotarget; 2018 Sep; 9(74):33912-33930. PubMed ID: 30338035
[TBL] [Abstract][Full Text] [Related]
10. Cathepsin D plays a role in endothelial-pericyte interactions during alteration of the blood-retinal barrier in diabetic retinopathy.
Monickaraj F; McGuire P; Das A
FASEB J; 2018 May; 32(5):2539-2548. PubMed ID: 29263022
[TBL] [Abstract][Full Text] [Related]
11. Yeast as a tool to explore cathepsin D function.
Pereira H; Oliveira CS; Castro L; Preto A; Chaves SR; Côrte-Real M
Microb Cell; 2015 Jul; 2(7):225-234. PubMed ID: 28357298
[TBL] [Abstract][Full Text] [Related]
12. Cathepsin D: an Mϕ-derived factor mediating increased endothelial cell permeability with implications for alteration of the blood-retinal barrier in diabetic retinopathy.
Monickaraj F; McGuire PG; Nitta CF; Ghosh K; Das A
FASEB J; 2016 Apr; 30(4):1670-82. PubMed ID: 26718887
[TBL] [Abstract][Full Text] [Related]
13. Biologic roles of estrogen receptor-β and insulin-like growth factor-2 in triple-negative breast cancer.
Hamilton N; Márquez-Garbán D; Mah V; Fernando G; Elshimali Y; Garbán H; Elashoff D; Vadgama J; Goodglick L; Pietras R
Biomed Res Int; 2015; 2015():925703. PubMed ID: 25874233
[TBL] [Abstract][Full Text] [Related]
14. Procathepsin D and cancer: From molecular biology to clinical applications.
Vetvicka V; Vashishta A; Saraswat-Ohri S; Vetvickova J
World J Clin Oncol; 2010 Nov; 1(1):35-40. PubMed ID: 21603309
[TBL] [Abstract][Full Text] [Related]
15. IGF binding proteins (IGFBPs) and regulation of breast cancer biology.
Perks CM; Holly JM
J Mammary Gland Biol Neoplasia; 2008 Dec; 13(4):455-69. PubMed ID: 19031049
[TBL] [Abstract][Full Text] [Related]
16. Cathepsin D--many functions of one aspartic protease.
Benes P; Vetvicka V; Fusek M
Crit Rev Oncol Hematol; 2008 Oct; 68(1):12-28. PubMed ID: 18396408
[TBL] [Abstract][Full Text] [Related]
17. Insulin-like growth factor II mediates resveratrol stimulatory effect on cathepsin D in breast cancer cells.
Vyas S; Asmerom Y; De León DD
Growth Factors; 2006 Mar; 24(1):79-87. PubMed ID: 16393696
[TBL] [Abstract][Full Text] [Related]
18. Increased activity of lysosomal enzymes in the peritoneal fluid of patients with gynecologic cancers and pelvic inflammatory disease.
Beratis NG; Kaperonis A; Eliopoulou MI; Kourounis G; Tzingounis VA
J Cancer Res Clin Oncol; 2005 Jun; 131(6):371-6. PubMed ID: 15785934
[TBL] [Abstract][Full Text] [Related]
19. The role of biological markers as predictors of response to preoperative chemotherapy in large primary breast cancer.
Cocquyt VF; Schelfhout VR; Blondeel PN; Depypere HT; Daems KK; Serreyn RF; Praet MM; Van Belle SJ
Med Oncol; 2003; 20(3):221-31. PubMed ID: 14514971
[TBL] [Abstract][Full Text] [Related]
20. Hypertrophy of cultured adult rat ventricular cardiomyocytes induced by antibodies against the insulin-like growth factor (IGF)-I or the IGF-I receptor is IGF-II-dependent.
Huang CY; Hao LY; Buetow DE
Mol Cell Biochem; 2002 Apr; 233(1-2):65-72. PubMed ID: 12083381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
